Introducing IPC’s Newly Appointed Councilors – June 2025

We’re excited to introduce the newest additions to the IPC Councilor network: Mario Amaya, Claudia Romina Contreras, Paula Luna, Annika Smith, and Maria Victoria Suarez Restrepo. Appointed this month by the IPC Board of Directors, these dermatologists bring a wealth of experience and a shared dedication to improving outcomes for people living with psoriasis.

As IPC Councilors, they will actively support our mission of advancing education, knowledge, research, and care by promoting best practices in treatment globally.

Get to know these leaders and learn more about their contributions to the field. We’re honored to welcome them to the IPC community.

Mario Amaya, MD

University of Monterrey

Monterrey, Mexico

IPC Councilor

Bio

Romina Contreras, MSc, MD

Hospital de Clinicas

Asunción, Paraguay

IPC Councilor

Bio

Paula Carolina Luna, MD

Hospital Aleman

Capital Federal, Argentina

IPC Councilor

Bio

Annika Smith, MBBS (HONS1), MPHTM, FRACP, FAAD

The Skin Hospital, Darlinghurst

Sydney, Australia

IPC Councilor

Bio

Maria Victoria Suarez Restrepo, MD

Hospital do Servidor Publico Municipal de São Paulo

São Paulo, Brazil

IPC Councilor

Bio

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

Also Read

Six people stand side by side in business attire, smiling at the camera. Behind them, a banner reads IPC International Council 2025 Think Tank Puerto Rico, focused on Psoriasis in Latin America, with colorful designs and sunlight filtering through curtains.

dermatology fellowship

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.

Wednesday, April 29, 2026

Map of South America with logos of IFPA, IPC, GRAPPA, PANLAR, SOLAPSO, and COLAPPIEL—organizations related to psoriasis and rheumatology—displayed around the continent.

psoriatic arthritis care

International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America

A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.

Monday, April 27, 2026

Banner for the International Psoriasis Council featuring the text Councilor Spotlight, with headshots of IPC Councilors—a woman and a man—in separate frames below. The background showcases colorful geometric patterns in the corners.

education

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.

Tuesday, April 21, 2026

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Monday, April 27, 2026

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.

Tuesday, April 28, 2026

International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America

A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.

Monday, April 27, 2026

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

Wednesday, April 29, 2026

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.

Tuesday, April 21, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Introducing IPC’s Newly Appointed Councilors – June 2025

University of Monterrey

Monterrey, Mexico

IPC Councilor

Hospital de Clinicas

Asunción, Paraguay

IPC Councilor

Hospital Aleman

Capital Federal, Argentina

IPC Councilor

The Skin Hospital, Darlinghurst

Sydney, Australia

IPC Councilor

Hospital do Servidor Publico Municipal de São Paulo

São Paulo, Brazil

IPC Councilor

Categories

Recent Posts

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

Also Read

Subscribe to the IPC Newsletter

What's New

Recent Advances in Psoriasis: A Year in Review

Monday, April 6, 2026